Matches in SemOpenAlex for { <https://semopenalex.org/work/W2774935430> ?p ?o ?g. }
- W2774935430 abstract "Objective: Idiopathic pulmonary fibrosis is an irreversible and progressive fibrotic lung disease that leads to declines in pulmonary function and, eventually, respiratory failure and has no effective treatment. Gly-His-Lys (GHK) is a tripeptide involved in the processes of tissue regeneration and wound healing and has significant inhibitory effects on transforming growth factor (TGF)-β1 secretion. The effect of GHK on fibrogenesis in pulmonary fibrosis and the exact underlying mechanism have not been studied previously. Thus, this study investigated the effects of GHK on bleomycin (BLM)-induced fibrosis and identified the pathway that is potentially responsible for these effects. Methods: Intratracheal injections of 3 mg/kg BLM were administered to induce pulmonary fibrosis in C57BL/6 mice. GHK was administered intraperitoneally at doses of 2.6, 26, and 260 μg/ml/day every other day from the 4th to the 21st day after BLM instillation. Three weeks after BLM instillation, pulmonary injury and pulmonary fibrosis was evaluated by the hematoxylin-eosin (HE) and Masson's trichrome (MT) staining. Chronic inflammation index was used for the histological assessments by two pathologists blindly to each other. Tumor necrosis factor (TNF)-α and IL-6 levels in BALF and myeloperoxidase (MPO) activity in lung extracts were measured. For the pulmonary fibrosis evaluation, the fibrosis index calculated based on MT staining, collagen deposition and active TGF-β1 expression detected by ELISA, and the expression of TGF-β1, α-smooth muscle actin (SMA), fibronectin, MMP-9, and TIMP-1 by western blotting. The epithelial mesenchymal transition index, E-cadherin, and vimentin was also detected by western blot. The statistical analysis was performed by one-way ANOVA and the comparison between different groups were performed. Results: Treatment with GHK at all three doses reduced inflammatory cell infiltration and interstitial thickness and attenuated BLM-induced pulmonary fibrosis in mice. GHK treatment significantly improved collagen deposition, and MMP-9/TIMP-1 imbalances in lung tissue and also reduced TNF-α, IL-6 expression in bronchoalveolar lavage fluid (BALF) and MPO in lung extracts. Furthermore, GHK reversed BLM-induced increases in TGF-β1, p-Smad2, p-Smad-3 and insulin-like growth factor-1 (IGF-1) expression. Conclusion: GHK inhibits BLM-induced fibrosis progression, the inflammatory response and EMT via the TGF-β1/Smad 2/3 and IGF-1 pathway. Thus, GHK may be a potential treatment for pulmonary fibrosis." @default.
- W2774935430 created "2017-12-22" @default.
- W2774935430 creator A5036423556 @default.
- W2774935430 creator A5038936840 @default.
- W2774935430 creator A5059736060 @default.
- W2774935430 creator A5063127492 @default.
- W2774935430 creator A5063481044 @default.
- W2774935430 creator A5067226238 @default.
- W2774935430 creator A5072453212 @default.
- W2774935430 creator A5080754945 @default.
- W2774935430 creator A5087781186 @default.
- W2774935430 date "2017-12-12" @default.
- W2774935430 modified "2023-10-16" @default.
- W2774935430 title "GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition" @default.
- W2774935430 cites W106329705 @default.
- W2774935430 cites W1577226382 @default.
- W2774935430 cites W1889115072 @default.
- W2774935430 cites W1973073024 @default.
- W2774935430 cites W1978081956 @default.
- W2774935430 cites W1979807853 @default.
- W2774935430 cites W1986407289 @default.
- W2774935430 cites W1996764985 @default.
- W2774935430 cites W1997614336 @default.
- W2774935430 cites W2013537969 @default.
- W2774935430 cites W2017096535 @default.
- W2774935430 cites W2018566900 @default.
- W2774935430 cites W2026022954 @default.
- W2774935430 cites W2029195841 @default.
- W2774935430 cites W2031896302 @default.
- W2774935430 cites W2042268825 @default.
- W2774935430 cites W2048604783 @default.
- W2774935430 cites W2051521659 @default.
- W2774935430 cites W2054458373 @default.
- W2774935430 cites W2054767679 @default.
- W2774935430 cites W2059651749 @default.
- W2774935430 cites W2065433570 @default.
- W2774935430 cites W2083517335 @default.
- W2774935430 cites W2083755620 @default.
- W2774935430 cites W2085060090 @default.
- W2774935430 cites W2091082450 @default.
- W2774935430 cites W2100880370 @default.
- W2774935430 cites W2113923441 @default.
- W2774935430 cites W2118173129 @default.
- W2774935430 cites W2126217408 @default.
- W2774935430 cites W2134903396 @default.
- W2774935430 cites W2141366082 @default.
- W2774935430 cites W2144186997 @default.
- W2774935430 cites W2159751547 @default.
- W2774935430 cites W2160001887 @default.
- W2774935430 cites W2160383526 @default.
- W2774935430 cites W2160698607 @default.
- W2774935430 cites W2178527396 @default.
- W2774935430 cites W2221740556 @default.
- W2774935430 cites W2474397968 @default.
- W2774935430 cites W2493093950 @default.
- W2774935430 cites W2604120386 @default.
- W2774935430 cites W2735790845 @default.
- W2774935430 cites W3825304 @default.
- W2774935430 doi "https://doi.org/10.3389/fphar.2017.00904" @default.
- W2774935430 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5733019" @default.
- W2774935430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29311918" @default.
- W2774935430 hasPublicationYear "2017" @default.
- W2774935430 type Work @default.
- W2774935430 sameAs 2774935430 @default.
- W2774935430 citedByCount "33" @default.
- W2774935430 countsByYear W27749354302018 @default.
- W2774935430 countsByYear W27749354302019 @default.
- W2774935430 countsByYear W27749354302020 @default.
- W2774935430 countsByYear W27749354302021 @default.
- W2774935430 countsByYear W27749354302022 @default.
- W2774935430 countsByYear W27749354302023 @default.
- W2774935430 crossrefType "journal-article" @default.
- W2774935430 hasAuthorship W2774935430A5036423556 @default.
- W2774935430 hasAuthorship W2774935430A5038936840 @default.
- W2774935430 hasAuthorship W2774935430A5059736060 @default.
- W2774935430 hasAuthorship W2774935430A5063127492 @default.
- W2774935430 hasAuthorship W2774935430A5063481044 @default.
- W2774935430 hasAuthorship W2774935430A5067226238 @default.
- W2774935430 hasAuthorship W2774935430A5072453212 @default.
- W2774935430 hasAuthorship W2774935430A5080754945 @default.
- W2774935430 hasAuthorship W2774935430A5087781186 @default.
- W2774935430 hasBestOaLocation W27749354301 @default.
- W2774935430 hasConcept C118131993 @default.
- W2774935430 hasConcept C121608353 @default.
- W2774935430 hasConcept C126322002 @default.
- W2774935430 hasConcept C142724271 @default.
- W2774935430 hasConcept C147447768 @default.
- W2774935430 hasConcept C163031210 @default.
- W2774935430 hasConcept C185592680 @default.
- W2774935430 hasConcept C189165786 @default.
- W2774935430 hasConcept C204232928 @default.
- W2774935430 hasConcept C2776232574 @default.
- W2774935430 hasConcept C2776694085 @default.
- W2774935430 hasConcept C2777714996 @default.
- W2774935430 hasConcept C2778341716 @default.
- W2774935430 hasConcept C2779013556 @default.
- W2774935430 hasConcept C2780559512 @default.
- W2774935430 hasConcept C2781080636 @default.
- W2774935430 hasConcept C2781244666 @default.
- W2774935430 hasConcept C502942594 @default.